Utilizing past and present mouse systems to engineer more relevant pancreatic cancer models

Frontiers in Physiology

Volumn 5, Issue Nov, 2014, Pages

  DeCant, Brian ^a   Principe, Daniel R ^a   Guerra, Carmen ^b   di Magliano, Marina Pasca ^c   Grippo, Paul J ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b Structural Biology and Biocomputing Programme   (Spain)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Conditional; Flp frt; Inducible; Kras; Mouse model; Pancreatic cancer

Indexed keywords

CRE RECOMBINASE; DOXYCYCLINE; GEFITINIB; TRANSFORMING GROWTH FACTOR BETA;

ACINAR CELL; ADIPOSE TISSUE; CANCER GROWTH; CANCER MODEL; CANCER STAGING; CELL PROLIFERATION; ENZYME ACTIVATION; EPITHELIUM; GENE; GENE DELETION; GENE EXPRESSION; GENE MUTATION; HEMATOPOIETIC TISSUE; HUMAN; KRAS GENE; MESENCHYME; MOLECULAR MECHANICS; NONHUMAN; PANCREAS; PANCREAS CANCER; PDX1 GENE; PHENOTYPE; PTF1A GENE; REVIEW; TRANSGENIC MOUSE; TUMOR MICROENVIRONMENT;

EID: 84911907924     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2014.00464     Document Type: Review

References (114)

1. Aguirre, A.J., Bardeesy, N., Sinha, M., Lopez, L., Tuveson, D.A., Horner, J., Redston, M.S., and Depinho, R.A. (2003). Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. Genes Dev 17, 3112-3126. doi: 10.1101/gad.1158703.
2. Alonzi, T., Maritano, D., Gorgoni, B., Rizzuto, G., Libert, C., and Poli, V. (2001). Essential role of STAT3 in the control of the acute-phase response as revealed by inducible gene inactivation [correction of activation] in the liver. Mol Cell Biol 21, 1621-1632. doi: 10.1128/MCB.21.5.1621-1632.2001.
3. Ardito, C.M., Gruner, B.M., Takeuchi, K.K., Lubeseder-Martellato, C., Teichmann, N., Mazur, P.K., Delgiorno, K.E., Carpenter, E.S., Halbrook, C.J., Hall, J.C., Pal, D., Briel, T., Herner, A., Trajkovic-Arsic, M., Sipos, B., Liou, G.Y., Storz, P., Murray, N.R., Threadgill, D.W., Sibilia, M., Washington, M.K., Wilson, C.L., Schmid, R.M., Raines, E.W., Crawford, H.C., and Siveke, J.T. (2012). EGF receptor is required for KRAS-induced pancreatic tumorigenesis. Cancer Cell 22, 304-317. doi: 10.1016/j.ccr.2012.07.024.
4. Bardeesy, N., Cheng, K.H., Berger, J.H., Chu, G.C., Pahler, J., Olson, P., Hezel, A.F., Horner, J., Lauwers, G.Y., Hanahan, D., and Depinho, R.A. (2006). Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer. Genes Dev 20, 3130-3146. doi: 10.1101/gad.1478706.
5. Bardeesy, N., Morgan, J., Sinha, M., Signoretti, S., Srivastava, S., Loda, M., Merlino, G., and Depinho, R.A. (2002). Obligate roles for p16(Ink4a) and p19(Arf)-p53 in the suppression of murine pancreatic neoplasia. Mol Cell Biol 22, 635-643.
6. Belteki, G., Haigh, J., Kabacs, N., Haigh, K., Sison, K., Costantini, F., Whitsett, J., Quaggin, S.E., and Nagy, A. (2005). Conditional and inducible transgene expression in mice through the combinatorial use of Cre-mediated recombination and tetracycline induction. Nucleic Acids Res 33, e51. doi: 10.1093/nar/gni051.
7. Berry, R., and Rodeheffer, M.S. (2013). Characterization of the adipocyte cellular lineage in vivo. Nat Cell Biol 15, 302-308. doi: 10.1038/ncb2696.
8. Bhowmick, N.A., Chytil, A., Plieth, D., Gorska, A.E., Dumont, N., Shappell, S., Washington, M.K., Neilson, E.G., and Moses, H.L. (2004). TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 303, 848-851. doi: 10.1126/science.1090922.
9. Boillee, S., Yamanaka, K., Lobsiger, C.S., Copeland, N.G., Jenkins, N.A., Kassiotis, G., Kollias, G., and Cleveland, D.W. (2006). Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312, 1389-1392. doi: 10.1126/science.1123511.
10. Borazanci, E., and Von Hoff, D.D. (2014). Nab-paclitaxel and gemcitabine for the treatment of patients with metastatic pancreatic cancer. Expert Rev Gastroenterol Hepatol 8, 739-747. doi: 10.1586/17474124.2014.925799.
11. Buza-Vidas, N., Woll, P., Hultquist, A., Duarte, S., Lutteropp, M., Bouriez-Jones, T., Ferry, H., Luc, S., and Jacobsen, S.E. (2011). FLT3 expression initiates in fully multipotent mouse hematopoietic progenitor cells. Blood 118, 1544-1548. doi: 10.1182/blood-2010-10-316232.
12. Calaminus, S.D., Guitart, A.V., Sinclair, A., Schachtner, H., Watson, S.P., Holyoake, T.L., Kranc, K.R., and Machesky, L.M. (2012). Lineage tracing of Pf4-Cre marks hematopoietic stem cells and their progeny. PLoS One 7, e51361. doi: 10.1371/journal.pone.0051361.
13. Carriere, C., Gore, A.J., Norris, A.M., Gunn, J.R., Young, A.L., Longnecker, D.S., and Korc, M. (2011a). Deletion of Rb accelerates pancreatic carcinogenesis by oncogenic Kras and impairs senescence in premalignant lesions. Gastroenterology 141, 1091-1101. doi: 10.1053/j.gastro.2011.05.041.
14. Carriere, C., Seeley, E.S., Goetze, T., Longnecker, D.S., and Korc, M. (2007). The Nestin progenitor lineage is the compartment of origin for pancreatic intraepithelial neoplasia. Proc Natl Acad Sci U S A 104, 4437-4442. doi: 10.1073/pnas.0701117104.
15. Carriere, C., Young, A.L., Gunn, J.R., Longnecker, D.S., and Korc, M. (2011b). Acute pancreatitis accelerates initiation and progression to pancreatic cancer in mice expressing oncogenic Kras in the nestin cell lineage. PLoS One 6, e27725. doi: 10.1371/journal.pone.0027725.
16. Chen, H., Zhuang, F., Liu, Y.H., Xu, B., Del Moral, P., Deng, W., Chai, Y., Kolb, M., Gauldie, J., Warburton, D., Moses, H.L., and Shi, W. (2008). TGF-beta receptor II in epithelia versus mesenchyme plays distinct roles in the developing lung. Eur Respir J 32, 285-295. doi: 10.1183/09031936.00165407.
17. Choi, Y.I., Duke-Cohan, J.S., Tan, J., Gui, J., Singh, M.K., Epstein, J.A., and Reinherz, E.L. (2013). Plxnd1 expression in thymocytes regulates their intrathymic migration while that in thymic endothelium impacts medullary topology. Front Immunol 4, 392. doi: 10.3389/fimmu.2013.00392.
18. Clausen, B.E., Burkhardt, C., Reith, W., Renkawitz, R., and Forster, I. (1999). Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res 8, 265-277.
19. Cole, B.K., Morris, M.A., Grzesik, W.J., Leone, K.A., and Nadler, J.L. (2012). Adipose tissue specific deletion of 12/15-lipoxygenase protects mice from the consequences of a high-fat diet. Mediators Inflamm 2012, 851798. doi: 10.1155/2012/851798.
20. Collins, M.A., Bednar, F., Zhang, Y., Brisset, J.C., Galban, S., Galban, C.J., Rakshit, S., Flannagan, K.S., Adsay, N.V., and Pasca Di Magliano, M. (2012a). Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice. J Clin Invest 122, 639-653. doi: 10.1172/JCI59227.
21. Collins, M.A., Brisset, J.C., Zhang, Y., Bednar, F., Pierre, J., Heist, K.A., Galban, C.J., Galban, S., and Di Magliano, M.P. (2012b). Metastatic pancreatic cancer is dependent on oncogenic Kras in mice. PLoS One 7, e49707. doi: 10.1371/journal.pone.0049707.
22. Dali-Youcef, N., Mataki, C., Coste, A., Messaddeq, N., Giroud, S., Blanc, S., Koehl, C., Champy, M.F., Chambon, P., Fajas, L., Metzger, D., Schoonjans, K., and Auwerx, J. (2007). Adipose tissue-specific inactivation of the retinoblastoma protein protects against diabesity because of increased energy expenditure. Proc Natl Acad Sci U S A 104, 10703-10708. doi: 10.1073/pnas.0611568104.
23. Daniluk, J., Liu, Y., Deng, D., Chu, J., Huang, H., Gaiser, S., Cruz-Monserrate, Z., Wang, H., Ji, B., and Logsdon, C.D. (2012). An NF-kappaB pathway-mediated positive feedback loop amplifies Ras activity to pathological levels in mice. J Clin Invest 122, 1519-1528. doi: 10.1172/JCI59743.
24. Daria, D., Filippi, M.D., Knudsen, E.S., Faccio, R., Li, Z., Kalfa, T., and Geiger, H. (2008). The retinoblastoma tumor suppressor is a critical intrinsic regulator for hematopoietic stem and progenitor cells under stress. Blood 111, 1894-1902. doi: 10.1182/blood-2007-02-071746.
25. Dawson, D.W., Hertzer, K., Moro, A., Donald, G., Chang, H.H., Go, V.L., Pandol, S.J., Lugea, A., Gukovskaya, A.S., Li, G., Hines, O.J., Rozengurt, E., and Eibl, G. (2013). High-fat, high calorie diet promotes early pancreatic neoplasia in the conditional KrasG12D mouse model. Cancer Prev Res (Phila) 6, 1064-1073. doi: 10.1158/1940-6207.CAPR-13-0065.
26. De La, O.J., Emerson, L.L., Goodman, J.L., Froebe, S.C., Illum, B.E., Curtis, A.B., and Murtaugh, L.C. (2008). Notch and Kras reprogram pancreatic acinar cells to ductal intraepithelial neoplasia. Proc Natl Acad Sci U S A 105, 18907-18912. doi: 10.1073/pnas.0810111105.
27. Delacour, A., Nepote, V., Trumpp, A., and Herrera, P.L. (2004). Nestin expression in pancreatic exocrine cell lineages. Mech Dev 121, 3-14.
28. Desai, B.M., Oliver-Krasinski, J., De Leon, D.D., Farzad, C., Hong, N., Leach, S.D., and Stoffers, D.A. (2007). Preexisting pancreatic acinar cells contribute to acinar cell, but not islet beta cell, regeneration. J Clin Invest 117, 971-977. doi: 10.1172/JCI29988.
29. Dymecki, S.M. (1996). Flp recombinase promotes site-specific DNA recombination in embryonic stem cells and transgenic mice. Proc Natl Acad Sci U S A 93, 6191-6196.
30. Feig, C., Jones, J.O., Kraman, M., Wells, R.J., Deonarine, A., Chan, D.S., Connell, C.M., Roberts, E.W., Zhao, Q., Caballero, O.L., Teichmann, S.A., Janowitz, T., Jodrell, D.I., Tuveson, D.A., and Fearon, D.T. (2013). Targeting CXCL12 from FAP-expressing carcinoma associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer. Proc Natl Acad Sci U S A 110, 20212-20217. doi: 10.1073/pnas.1320318110.
31. Feil, R., Brocard, J., Mascrez, B., Lemeur, M., Metzger, D., and Chambon, P. (1996). Ligand activated site-specific recombination in mice. Proc Natl Acad Sci U S A 93, 10887-10890.
32. Feil, R., Wagner, J., Metzger, D., and Chambon, P. (1997). Regulation of Cre recombinase activity by mutated estrogen receptor ligand-binding domains. Biochem Biophys Res Commun 237, 752-757. doi: 10.1006/bbrc.1997.7124.
33. Fernandez-Zapico, M.E., Gonzalez-Paz, N.C., Weiss, E., Savoy, D.N., Molina, J.R., Fonseca, R., Smyrk, T.C., Chari, S.T., Urrutia, R., and Billadeau, D.D. (2005). Ectopic expression of VAV1 reveals an unexpected role in pancreatic cancer tumorigenesis. Cancer Cell 7, 39-49. doi: 10.1016/j.ccr.2004.11.024.
34. Fisher, G.H., Wellen, S.L., Klimstra, D., Lenczowski, J.M., Tichelaar, J.W., Lizak, M.J., Whitsett, J.A., Koretsky, A., and Varmus, H.E. (2001). Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes. Genes Dev 15, 3249-3262. doi: 10.1101/gad.947701.
35. Frese, K.K., and Tuveson, D.A. (2007). Maximizing mouse cancer models. Nat Rev Cancer 7, 645-658. doi: 10.1038/nrc2192.
36. Gidekel Friedlander, S.Y., Chu, G.C., Snyder, E.L., Girnius, N., Dibelius, G., Crowley, D., Vasile, E., Depinho, R.A., and Jacks, T. (2009). Context-dependent transformation of adult pancreatic cells by oncogenic K-Ras. Cancer Cell 16, 379-389. doi: 10.1016/j.ccr.2009.09.027.
37. Gore, J., and Korc, M. (2014). Pancreatic cancer stroma: friend or foe? Cancer Cell 25, 711-712. doi: 10.1016/j.ccr.2014.05.026.
38. Gottlieb, K.A., and Villarreal, L.P. (2001). Natural biology of polyomavirus middle T antigen. Microbiol Mol Biol Rev 65, 288-318; second and third pages, table of contents. doi: 10.1128/MMBR.65.2.288-318.2001.
39. Greenbaum, A., Hsu, Y.M., Day, R.B., Schuettpelz, L.G., Christopher, M.J., Borgerding, J.N., Nagasawa, T., and Link, D.C. (2013). CXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell maintenance. Nature 495, 227-230. doi: 10.1038/nature11926.
40. Greten, F.R., Wagner, M., Weber, C.K., Zechner, U., Adler, G., and Schmid, R.M. (2001). TGF alpha transgenic mice. A model of pancreatic cancer development. Pancreatology 1, 363-368.
41. Grippo, P.J., Nowlin, P.S., Demeure, M.J., Longnecker, D.S., and Sandgren, E.P. (2003). Preinvasive pancreatic neoplasia of ductal phenotype induced by acinar cell targeting of mutant Kras in transgenic mice. Cancer Res 63, 2016-2019.
42. Grippo, P.J., and Sandgren, E.P. (2012). Acinar-to-ductal metaplasia accompanies c-myc induced exocrine pancreatic cancer progression in transgenic rodents. Int J Cancer 131, 1243-1248. doi: 10.1002/ijc.27322.
43. Guerra, C., and Barbacid, M. (2013). Genetically engineered mouse models of pancreatic adenocarcinoma. Mol Oncol 7, 232-247. doi: 10.1016/j.molonc.2013.02.002.
44. Guerra, C., Collado, M., Navas, C., Schuhmacher, A.J., Hernandez-Porras, I., Canamero, M., Rodriguez-Justo, M., Serrano, M., and Barbacid, M. (2011). Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence. Cancer Cell 19, 728-739. doi: 10.1016/j.ccr.2011.05.011.
45. Guerra, C., Mijimolle, N., Dhawahir, A., Dubus, P., Barradas, M., Serrano, M., Campuzano, V., and Barbacid, M. (2003). Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context. Cancer Cell 4, 111-120.
46. Guerra, C., Schuhmacher, A.J., Canamero, M., Grippo, P.J., Verdaguer, L., Perez-Gallego, L., Dubus, P., Sandgren, E.P., and Barbacid, M. (2007). Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice. Cancer Cell 11, 291-302. doi: 10.1016/j.ccr.2007.01.012.
47. Habbe, N., Shi, G., Meguid, R.A., Fendrich, V., Esni, F., Chen, H., Feldmann, G., Stoffers, D.A., Konieczny, S.F., Leach, S.D., and Maitra, A. (2008). Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult mice. Proc Natl Acad Sci U S A 105, 18913-18918. doi: 10.1073/pnas.0810097105.
48. Hahn, S.A., Schutte, M., Hoque, A.T., Moskaluk, C.A., Da Costa, L.T., Rozenblum, E., Weinstein, C.L., Fischer, A., Yeo, C.J., Hruban, R.H., and Kern, S.E. (1996). DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271, 350-353.
49. Hezel, A.F., Kimmelman, A.C., Stanger, B.Z., Bardeesy, N., and Depinho, R.A. (2006). Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev 20, 1218-1249. doi: 10.1101/gad.1415606.
50. Hill, R., Li, Y., Tran, L.M., Dry, S., Calvopina, J.H., Garcia, A., Kim, C., Wang, Y., Donahue, T.R., Herschman, H.R., and Wu, H. (2012). Cell intrinsic role of COX-2 in pancreatic cancer development. Mol Cancer Ther 11, 2127-2137. doi: 10.1158/1535-7163.MCT-12-0342.
51. Hingorani, S.R., Petricoin, E.F., Maitra, A., Rajapakse, V., King, C., Jacobetz, M.A., Ross, S., Conrads, T.P., Veenstra, T.D., Hitt, B.A., Kawaguchi, Y., Johann, D., Liotta, L.A., Crawford, H.C., Putt, M.E., Jacks, T., Wright, C.V., Hruban, R.H., Lowy, A.M., and Tuveson, D.A. (2003). Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 4, 437-450.
52. Hingorani, S.R., Wang, L., Multani, A.S., Combs, C., Deramaudt, T.B., Hruban, R.H., Rustgi, A.K., Chang, S., and Tuveson, D.A. (2005). Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell 7, 469-483. doi: 10.1016/j.ccr.2005.04.023.
53. Hruban, R.H., Adsay, N.V., Albores-Saavedra, J., Anver, M.R., Biankin, A.V., Boivin, G.P., Furth, E.E., Furukawa, T., Klein, A., Klimstra, D.S., Kloppel, G., Lauwers, G.Y., Longnecker, D.S., Luttges, J., Maitra, A., Offerhaus, G.J., Perez-Gallego, L., Redston, M., and Tuveson, D.A. (2006). Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations. Cancer Res 66, 95-106. doi: 10.1158/0008-5472.CAN-05-2168.
54. Ijichi, H., Chytil, A., Gorska, A.E., Aakre, M.E., Fujitani, Y., Fujitani, S., Wright, C.V., and Moses, H.L. (2006). Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-beta signaling in cooperation with active Kras expression. Genes Dev 20, 3147-3160. doi: 10.1101/gad.1475506.
55. Izeradjene, K., Combs, C., Best, M., Gopinathan, A., Wagner, A., Grady, W.M., Deng, C.X., Hruban, R.H., Adsay, N.V., Tuveson, D.A., and Hingorani, S.R. (2007). Kras(G12D) and Smad4/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas. Cancer Cell 11, 229-243. doi: 10.1016/j.ccr.2007.01.017.
56. Ji, B., Tsou, L., Wang, H., Gaiser, S., Chang, D.Z., Daniluk, J., Bi, Y., Grote, T., Longnecker, D.S., and Logsdon, C.D. (2009). Ras activity levels control the development of pancreatic diseases. Gastroenterology 137, 1072-1082, 1082 e1071-1076. doi: 10.1053/j.gastro.2009.05.052.
57. Jones, S., Zhang, X., Parsons, D.W., Lin, J.C., Leary, R.J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., Hong, S.M., Fu, B., Lin, M.T., Calhoun, E.S., Kamiyama, M., Walter, K., Nikolskaya, T., Nikolsky, Y., Hartigan, J., Smith, D.R., Hidalgo, M., Leach, S.D., Klein, A.P., Jaffee, E.M., Goggins, M., Maitra, A., Iacobuzio-Donahue, C., Eshleman, J.R., Kern, S.E., Hruban, R.H., Karchin, R., Papadopoulos, N., Parmigiani, G., Vogelstein, B., Velculescu, V.E., and Kinzler, K.W. (2008). Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321, 1801-1806. doi: 10.1126/science.1164368.
58. Jonkers, J., Meuwissen, R., Van Der Gulden, H., Peterse, H., Van Der Valk, M., and Berns, A. (2001). Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Nat Genet 29, 418-425. doi: 10.1038/ng747.
59. Kawaguchi, Y., Cooper, B., Gannon, M., Ray, M., Macdonald, R.J., and Wright, C.V. (2002). The role of the transcriptional regulator Ptf1a in converting intestinal to pancreatic progenitors. Nat Genet 32, 128-134. doi: 10.1038/ng959.
60. Kojima, K., Vickers, S.M., Adsay, N.V., Jhala, N.C., Kim, H.G., Schoeb, T.R., Grizzle, W.E., and Klug, C.A. (2007). Inactivation of Smad4 accelerates Kras(G12D)-mediated pancreatic neoplasia. Cancer Res 67, 8121-8130. doi: 10.1158/0008-5472.CAN-06-4167.
61. Kopinke, D., Brailsford, M., Pan, F.C., Magnuson, M.A., Wright, C.V., and Murtaugh, L.C. (2012). Ongoing Notch signaling maintains phenotypic fidelity in the adult exocrine pancreas. Dev Biol 362, 57-64. doi: 10.1016/j.ydbio.2011.11.010.
62. Kovacic, B., Hoelbl-Kovacic, A., Fischhuber, K.M., Leitner, N.R., Gotthardt, D., Casanova, E., Sexl, V., and Muller, M. (2014). Lactotransferrin-Cre reporter mice trace neutrophils, monocytes/macrophages and distinct subtypes of dendritic cells. Haematologica 99, 1006-1015. doi: 10.3324/haematol.2013.097154.
63. Kraman, M., Bambrough, P.J., Arnold, J.N., Roberts, E.W., Magiera, L., Jones, J.O., Gopinathan, A., Tuveson, D.A., and Fearon, D.T. (2010). Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha. Science 330, 827-830. doi: 10.1126/science.1195300.
64. Krimpenfort, P., Quon, K.C., Mooi, W.J., Loonstra, A., and Berns, A. (2001). Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice. Nature 413, 83-86. doi: 10.1038/35092584.
65. Lewis, B.C., Klimstra, D.S., and Varmus, H.E. (2003). The c-myc and PyMT oncogenes induce different tumor types in a somatic mouse model for pancreatic cancer. Genes Dev 17, 3127-3138. doi: 10.1101/gad.1140403.
66. Lin, H.V., and Accili, D. (2011). Reconstitution of insulin action in muscle, white adipose tissue, and brain of insulin receptor knock-out mice fails to rescue diabetes. J Biol Chem 286, 9797-9804. doi: 10.1074/jbc. M110.210807.
67. Liu, Y., Wang, L., Fatahi, R., Kronenberg, M., Kalajzic, I., Rowe, D., Li, Y., and Maye, P. (2010). Isolation of murine bone marrow derived mesenchymal stem cells using Twist2 Cre transgenic mice. Bone 47, 916-925. doi: 10.1016/j.bone.2010.07.022.
68. Logsdon, C.D., and Ji, B. (2009). Ras activity in acinar cells links chronic pancreatitis and pancreatic cancer. Clin Gastroenterol Hepatol 7, S40-43. doi: 10.1016/j.cgh.2009.07.040.
69. Maekawa, Y., Minato, Y., Ishifune, C., Kurihara, T., Kitamura, A., Kojima, H., Yagita, H., Sakata-Yanagimoto, M., Saito, T., Taniuchi, I., Chiba, S., Sone, S., and Yasutomo, K. (2008). Notch2 integrates signaling by the transcription factors RBP-J and CREB1 to promote T cell cytotoxicity. Nat Immunol 9, 1140-1147. doi: 10.1038/ni.1649.
70. Mirus, J.E., Zhang, Y., Hollingsworth, M.A., Solan, J.L., Lampe, P.D., and Hingorani, S.R. (2014). Spatiotemporal proteomic analyses during pancreas cancer progression identifies STK4 as a novel candidate biomarker for early stage disease. Mol Cell Proteomics. doi: 10.1074/mcp. M113.036517.
71. Mohammed, A., Janakiram, N.B., Li, Q., Madka, V., Ely, M., Lightfoot, S., Crawford, H., Steele, V.E., and Rao, C.V. (2010). The epidermal growth factor receptor inhibitor gefitinib prevents the progression of pancreatic lesions to carcinoma in a conditional LSL KrasG12D/+ transgenic mouse model. Cancer Prev Res (Phila) 3, 1417-1426. doi: 10.1158/1940-6207.CAPR-10-0038.
72. Morton, J.P., Klimstra, D.S., Mongeau, M.E., and Lewis, B.C. (2008). Trp53 deletion stimulates the formation of metastatic pancreatic tumors. Am J Pathol 172, 1081-1087. doi: 10.2353/ajpath.2008.070778.
73. Mullican, S.E., Tomaru, T., Gaddis, C.A., Peed, L.C., Sundaram, A., and Lazar, M.A. (2013). A novel adipose-specific gene deletion model demonstrates potential pitfalls of existing methods. Mol Endocrinol 27, 127-134. doi: 10.1210/me.2012-1267.
74. Navas, C., Hernandez-Porras, I., Schuhmacher, A.J., Sibilia, M., Guerra, C., and Barbacid, M. (2012). EGF receptor signaling is essential for k-ras oncogene-driven pancreatic ductal adenocarcinoma. Cancer Cell 22, 318-330. doi: 10.1016/j.ccr.2012.08.001.
75. Neesse, A., Michl, P., Frese, K.K., Feig, C., Cook, N., Jacobetz, M.A., Lolkema, M.P., Buchholz, M., Olive, K.P., Gress, T.M., and Tuveson, D.A. (2011). Stromal biology and therapy in pancreatic cancer. Gut 60, 861-868. doi: 10.1136/gut.2010.226092.
76. Obata, J., Yano, M., Mimura, H., Goto, T., Nakayama, R., Mibu, Y., Oka, C., and Kawaichi, M. (2001). p48 subunit of mouse PTF1 binds to RBP-Jkappa/CBF-1, the intracellular mediator of Notch signalling, and is expressed in the neural tube of early stage embryos. Genes Cells 6, 345-360.
77. Ohlsson, H., Karlsson, K., and Edlund, T. (1993). IPF1, a homeodomain-containing transactivator of the insulin gene. EMBO J 12, 4251-4259.
78. Olive, K.P., Jacobetz, M.A., Davidson, C.J., Gopinathan, A., Mcintyre, D., Honess, D., Madhu, B., Goldgraben, M.A., Caldwell, M.E., Allard, D., Frese, K.K., Denicola, G., Feig, C., Combs, C., Winter, S.P., Ireland-Zecchini, H., Reichelt, S., Howat, W.J., Chang, A., Dhara, M., Wang, L., Ruckert, F., Grutzmann, R., Pilarsky, C., Izeradjene, K., Hingorani, S.R., Huang, P., Davies, S.E., Plunkett, W., Egorin, M., Hruban, R.H., Whitebread, N., Mcgovern, K., Adams, J., Iacobuzio-Donahue, C., Griffiths, J., and Tuveson, D.A. (2009). Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 324, 1457-1461. doi: 10.1126/science.1171362.
79. Olive, K.P., Tuveson, D.A., Ruhe, Z.C., Yin, B., Willis, N.A., Bronson, R.T., Crowley, D., and Jacks, T. (2004). Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome. Cell 119, 847-860. doi: 10.1016/j.cell.2004.11.004.
80. Ornitz, D.M., Hammer, R.E., Messing, A., Palmiter, R.D., and Brinster, R.L. (1987). Pancreatic neoplasia induced by SV40 T-antigen expression in acinar cells of transgenic mice. Science 238, 188-193.
81. Ornitz, D.M., Palmiter, R.D., Messing, A., Hammer, R.E., Pinkert, C.A., and Brinster, R.L. (1985). Elastase I promoter directs expression of human growth hormone and SV40 T antigen genes to pancreatic acinar cells in transgenic mice. Cold Spring Harb Symp Quant Biol 50, 399-409.
82. Orsulic, S. (2002). An RCAS-TVA-based approach to designer mouse models. Mamm Genome 13, 543-547. doi: 10.1007/s00335-002-4003-4.
83. Ozdemir, B.C., Pentcheva-Hoang, T., Carstens, J.L., Zheng, X., Wu, C.C., Simpson, T.R., Laklai, H., Sugimoto, H., Kahlert, C., Novitskiy, S.V., De Jesus-Acosta, A., Sharma, P., Heidari, P., Mahmood, U., Chin, L., Moses, H.L., Weaver, V.M., Maitra, A., Allison, J.P., Lebleu, V.S., and Kalluri, R. (2014). Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Cancer Cell 25, 719-734. doi: 10.1016/j.ccr.2014.04.005.
84. Papadatos-Pastos, D., Thillai, K., Rabbie, R., Ross, P., and Sarker, D. (2014). FOLFIRINOX - a new paradigm in the treatment of pancreatic cancer. Expert Rev Anticancer Ther 14, 1115-1125. doi: 10.1586/14737140.2014.957188.
85. Philip, B., Roland, C.L., Daniluk, J., Liu, Y., Chatterjee, D., Gomez, S.B., Ji, B., Huang, H., Wang, H., Fleming, J.B., Logsdon, C.D., and Cruz-Monserrate, Z. (2013). A high-fat diet activates oncogenic Kras and COX2 to induce development of pancreatic ductal adenocarcinoma in mice. Gastroenterology 145, 1449-1458. doi: 10.1053/j.gastro.2013.08.018.
86. Principe, D.R., Doll, J.A., Bauer, J., Jung, B., Munshi, H.G., Bartholin, L., Pasche, B., Lee, C., and Grippo, P.J. (2014). TGF-beta: duality of function between tumor prevention and carcinogenesis. J Natl Cancer Inst 106, djt369. doi: 10.1093/jnci/djt369.
87. Qiu, W., Sahin, F., Iacobuzio-Donahue, C.A., Garcia-Carracedo, D., Wang, W.M., Kuo, C.Y., Chen, D., Arking, D.E., Lowy, A.M., Hruban, R.H., Remotti, H.E., and Su, G.H. (2011). Disruption of p16 and activation of Kras in pancreas increase ductal adenocarcinoma formation and metastasis in vivo. Oncotarget 2, 862-873.
88. Quaife, C.J., Pinkert, C.A., Ornitz, D.M., Palmiter, R.D., and Brinster, R.L. (1987). Pancreatic neoplasia induced by ras expression in acinar cells of transgenic mice. Cell 48, 1023-1034.
89. Ray, K.C., Moss, M.E., Franklin, J.L., Weaver, C.J., Higginbotham, J., Song, Y., Revetta, F.L., Blaine, S.A., Bridges, L.R., Guess, K.E., Coffey, R.J., Crawford, H.C., Washington, M.K., and Means, A.L. (2014). Heparin-binding epidermal growth factor-like growth factor eliminates constraints on activated Kras to promote rapid onset of pancreatic neoplasia. Oncogene 33, 823-831. doi: 10.1038/onc.2013.3.
90. Rhim, A.D., Oberstein, P.E., Thomas, D.H., Mirek, E.T., Palermo, C.F., Sastra, S.A., Dekleva, E.N., Saunders, T., Becerra, C.P., Tattersall, I.W., Westphalen, C.B., Kitajewski, J., Fernandez-Barrena, M.G., Fernandez-Zapico, M.E., Iacobuzio-Donahue, C., Olive, K.P., and Stanger, B.Z. (2014). Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma. Cancer Cell 25, 735-747. doi: 10.1016/j.ccr.2014.04.021.
91. Riopel, M.M., Li, J., Liu, S., Leask, A., and Wang, R. (2013). beta1 integrin-extracellular matrix interactions are essential for maintaining exocrine pancreas architecture and function. Lab Invest 93, 31-40. doi: 10.1038/labinvest.2012.147.
92. Sadowski, P.D. (1995). The Flp recombinase of the 2-microns plasmid of Saccharomyces cerevisiae. Prog Nucleic Acid Res Mol Biol 51, 53-91.
93. Sanchez-Gurmaches, J., and Guertin, D.A. (2014). Adipocyte lineages: tracing back the origins of fat. Biochim Biophys Acta 1842, 340-351. doi: 10.1016/j.bbadis.2013.05.027.
94. Sandgren, E.P., Luetteke, N.C., Palmiter, R.D., Brinster, R.L., and Lee, D.C. (1990). Overexpression of TGF alpha in transgenic mice: induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast. Cell 61, 1121-1135.
95. Sandgren, E.P., Luetteke, N.C., Qiu, T.H., Palmiter, R.D., Brinster, R.L., and Lee, D.C. (1993). Transforming growth factor alpha dramatically enhances oncogene-induced carcinogenesis in transgenic mouse pancreas and liver. Mol Cell Biol 13, 320-330.
96. Sandgren, E.P., Quaife, C.J., Paulovich, A.G., Palmiter, R.D., and Brinster, R.L. (1991). Pancreatic tumor pathogenesis reflects the causative genetic lesion. Proc Natl Acad Sci U S A 88, 93-97.
97. Sano, M., Driscoll, D.R., De Jesus-Monge, W.E., Klimstra, D.S., and Lewis, B.C. (2014). Activated wnt signaling in stroma contributes to development of pancreatic mucinous cystic neoplasms. Gastroenterology 146, 257-267. doi: 10.1053/j.gastro.2013.09.044.
98. Schreiner, B., Baur, D.M., Fingerle, A.A., Zechner, U., Greten, F.R., Adler, G., Sipos, B., Kloppel, G., Hameister, H., and Schmid, R.M. (2003). Pattern of secondary genomic changes in pancreatic tumors of Tgf alpha/Trp53+/- transgenic mice. Genes Chromosomes Cancer 38, 240-248. doi: 10.1002/gcc.10285.
99. Sherman, M.H., Yu, R.T., Engle, D.D., Ding, N., Atkins, A.R., Tiriac, H., Collisson, E.A., Connor, F., Van Dyke, T., Kozlov, S., Martin, P., Tseng, T.W., Dawson, D.W., Donahue, T.R., Masamune, A., Shimosegawa, T., Apte, M.V., Wilson, J.S., Ng, B., Lau, S.L., Gunton, J.E., Wahl, G.M., Hunter, T., Drebin, J.A., O'dwyer, P.J., Liddle, C., Tuveson, D.A., Downes, M., and Evans, R.M. (2014). Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy. Cell 159, 80-93. doi: 10.1016/j.cell.2014.08.007.
100. Siveke, J.T., Einwachter, H., Sipos, B., Lubeseder-Martellato, C., Kloppel, G., and Schmid, R.M. (2007). Concomitant pancreatic activation of Kras(G12D) and Tgfa results in cystic papillary neoplasms reminiscent of human IPMN. Cancer Cell 12, 266-279. doi: 10.1016/j.ccr.2007.08.002.
101. Song, S.Y., Gannon, M., Washington, M.K., Scoggins, C.R., Meszoely, I.M., Goldenring, J.R., Marino, C.R., Sandgren, E.P., Coffey, R.J., Jr., Wright, C.V., and Leach, S.D. (1999). Expansion of Pdx1-expressing pancreatic epithelium and islet neogenesis in transgenic mice overexpressing transforming growth factor alpha. Gastroenterology 117, 1416-1426.
102. Tanigaki, K., Tsuji, M., Yamamoto, N., Han, H., Tsukada, J., Inoue, H., Kubo, M., and Honjo, T. (2004). Regulation of alphabeta/gammadelta T cell lineage commitment and peripheral T cell responses by Notch/RBP-J signaling. Immunity 20, 611-622.
103. Teng, Y., Kanasaki, K., Bardeesy, N., Sugimoto, H., and Kalluri, R. (2011). Deletion of Smad4 in fibroblasts leads to defective chondrocyte maturation and cartilage production in a TGFbeta type II receptor independent manner. Biochem Biophys Res Commun 407, 633-639. doi: 10.1016/j.bbrc.2011.02.142.
104. Tian, W., Ding, W., Kim, S., Xu, X., Pan, M., and Chen, S. (2013). Efficacy and safety profile of combining agents against epidermal growth factor receptor or vascular endothelium growth factor receptor with gemcitabine-based chemotherapy in patients with advanced pancreatic cancer: a meta-analysis. Pancreatology 13, 415-422. doi: 10.1016/j.pan.2013.04.195.
105. Tomita, S., Jiang, H.B., Ueno, T., Takagi, S., Tohi, K., Maekawa, S., Miyatake, A., Furukawa, A., Gonzalez, F.J., Takeda, J., Ichikawa, Y., and Takahama, Y. (2003). T cell-specific disruption of arylhydrocarbon receptor nuclear translocator (Arnt) gene causes resistance to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced thymic involution. J Immunol 171, 4113-4120.
106. Troeger, J.S., Mederacke, I., Gwak, G.Y., Dapito, D.H., Mu, X., Hsu, C.C., Pradere, J.P., Friedman, R.A., and Schwabe, R.F. (2012). Deactivation of hepatic stellate cells during liver fibrosis resolution in mice. Gastroenterology 143, 1073-1083 e1022. doi: 10.1053/j.gastro.2012.06.036.
107. Tuveson, D.A., Zhu, L., Gopinathan, A., Willis, N.A., Kachatrian, L., Grochow, R., Pin, C.L., Mitin, N.Y., Taparowsky, E.J., Gimotty, P.A., Hruban, R.H., Jacks, T., and Konieczny, S.F. (2006). Mist1-KrasG12D knock-in mice develop mixed differentiation metastatic exocrine pancreatic carcinoma and hepatocellular carcinoma. Cancer Res 66, 242-247. doi: 10.1158/0008-5472.CAN-05-2305.
108. Wagner, M., Greten, F.R., Weber, C.K., Koschnick, S., Mattfeldt, T., Deppert, W., Kern, H., Adler, G., and Schmid, R.M. (2001). A murine tumor progression model for pancreatic cancer recapitulating the genetic alterations of the human disease. Genes Dev 15, 286-293. doi: 10.1101/gad.184701.
109. Wendling, O., Bornert, J.M., Chambon, P., and Metzger, D. (2009). Efficient temporally controlled targeted mutagenesis in smooth muscle cells of the adult mouse. Genesis 47, 14-18. doi: 10.1002/dvg.20448.
110. Wu, Z., Yang, L., Cai, L., Zhang, M., Cheng, X., Yang, X., and Xu, J. (2007). Detection of epithelial to mesenchymal transition in airways of a bleomycin induced pulmonary fibrosis model derived from an alpha-smooth muscle actin-Cre transgenic mouse. Respir Res 8, 1. doi: 10.1186/1465-9921-8-1.
111. Young, N.P., Crowley, D., and Jacks, T. (2011). Uncoupling cancer mutations reveals critical timing of p53 loss in sarcomagenesis. Cancer Res 71, 4040-4047. doi: 10.1158/0008-5472.CAN-10-4563.
112. Yu, K., Xu, J., Liu, Z., Sosic, D., Shao, J., Olson, E.N., Towler, D.A., and Ornitz, D.M. (2003). Conditional inactivation of FGF receptor 2 reveals an essential role for FGF signaling in the regulation of osteoblast function and bone growth. Development 130, 3063-3074.
113. Zhang, S., Zhou, X., Lang, R.A., and Guo, F. (2012). RhoA of the Rho family small GTPases is essential for B lymphocyte development. PLoS One 7, e33773. doi: 10.1371/journal.pone.0033773.
114. Zheng, B., Zhang, Z., Black, C.M., De Crombrugghe, B., and Denton, C.P. (2002). Ligand dependent genetic recombination in fibroblasts: a potentially powerful technique for investigating gene function in fibrosis. Am J Pathol 160, 1609-1617. doi: 10.1016/S0002-9440(10)61108-X.